Characterizing the Mechanism of Doxorubicin Mediated SAT1 Induction in Triple-Negative Breast Cancer

被引：0
作者：
White, Chloe [1 ]
Liang, Caroline [1 ]
Velenosi, Thomas [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC, Canada
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2024年 / 102卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：37
相关论文
共 50 条
[41]   Targeting triple-negative breast cancer [J].
Kirkpatrick, Peter .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :21-21
[42]   Pathogenesis of Triple-Negative Breast Cancer [J].
Derakhshan, Fatemeh ;
Reis-Filho, Jorge S. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 :181-204
[43]   Imaging of triple-negative breast cancer [J].
Dogan, B. E. ;
Turnbull, L. W. .
ANNALS OF ONCOLOGY, 2012, 23 :23-29
[44]   Metastatic Triple-negative Breast Cancer [J].
Rakha, E. A. ;
Chan, S. .
CLINICAL ONCOLOGY, 2011, 23 (09) :587-600
[45]   Morphotypes of the triple-negative breast cancer [J].
Koleckova, M. ;
Kolar, Z. ;
Ehrmann, J. ;
Korinkova, G. ;
Trojanec, R. .
VIRCHOWS ARCHIV, 2017, 471 :S296-S296
[46]   Pembrolizumab for triple-negative breast cancer [J].
Stirrups, Robert .
LANCET ONCOLOGY, 2020, 21 (04) :E183-E183
[47]   Targeting triple-negative breast cancer [J].
Peter Kirkpatrick .
Nature Reviews Drug Discovery, 2009, 8 :21-21
[48]   Chemoimmunotherapy for Triple-Negative Breast Cancer [J].
Slomski, Anita .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24) :2521-2521
[49]   An overview of triple-negative breast cancer [J].
Pankaj Kumar ;
Rupali Aggarwal .
Archives of Gynecology and Obstetrics, 2016, 293 :247-269
[50]   New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin [J].
Cristina Alexandra Ciocan-Cȃrtiţă ;
Ancuţa Jurj ;
Lajos Raduly ;
Roxana Cojocneanu ;
Alin Moldovan ;
Valentina Pileczki ;
Laura-Ancuta Pop ;
Liviuţa Budişan ;
Cornelia Braicu ;
Schuyler S. Korban ;
Ioana Berindan-Neagoe .
Molecular and Cellular Biochemistry, 2020, 475 :285-299
12345